NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 177 filers reported holding NEVRO CORP in Q1 2019. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $10,949,000 | +13.2% | 66,042 | -4.8% | 0.13% | +12.5% |
| Q1 2021 | $9,676,000 | -65.5% | 69,363 | -57.2% | 0.11% | -66.4% |
| Q4 2020 | $28,034,000 | +249.9% | 161,954 | -21.4% | 0.33% | +326.9% |
| Q4 2018 | $8,013,000 | -31.8% | 206,053 | +0.0% | 0.08% | -20.4% |
| Q3 2018 | $11,745,000 | -17.5% | 206,052 | +15.6% | 0.10% | -9.3% |
| Q2 2018 | $14,236,000 | -16.3% | 178,287 | -9.2% | 0.11% | -15.6% |
| Q1 2018 | $17,017,000 | +26.5% | 196,343 | +0.8% | 0.13% | +36.2% |
| Q4 2017 | $13,449,000 | -30.8% | 194,803 | -8.9% | 0.09% | -32.4% |
| Q3 2017 | $19,444,000 | +4.7% | 213,949 | -14.2% | 0.14% | -1.4% |
| Q2 2017 | $18,568,000 | – | 249,470 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |